Thryv Therapeutics Revenue

Biotechnology Research • Montreal, Quebec, Canada • 21-50 Employees

Thryv Therapeutics revenue & valuation

Annual revenue	$2,395,540
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$7,700,000
Total funding	$5,000,000

Key Contacts at Thryv Therapeutics

Philip Sager

Co-Founder And Bod Observer

Alicia Schiavi

Associate Director Clinical Operations

Maroua Khalifa

Associate Director, Pharmaceutical Development

Delphine Labit

Research Director

Company overview

Headquarters	999, boulevard De Maisonneuve Ouest, Suite 1250, Montréal, Québec H3A 3L4, CA
Phone number	+15149730915
Websites	thryvtrx.com lqttrx.com
NAICS	541714
Founded	2019
Employees	21-50
Socials

Thryv Therapeutics Email Formats

Thryv Therapeutics uses 2 email formats. The most common is {first initial} (e.g., j@thryvtrx.com), used 76% of the time.

Format	Example	Percentage
{first initial}	j@thryvtrx.com	76%
{first name}	john@thryvtrx.com	24%

About Thryv Therapeutics

Thryv Therapeutics Inc. is a privately owned company based in Montreal, Quebec, Canada. Thryv Therapeutics is pioneering a precision medicine approach to treat Long QT Syndrome, heart failure, and atrial fibrillation with potent and selective inhibitors of Serum Glucocorticoid inducible Kinase. For more information, please visit www.thryvtrx.com.

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Entry

Vice President

Director

Employees by Department

Thryv Therapeutics has 14 employees across 9 departments.

Departments

Number of employees

Funding Data

Explore Thryv Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2023-07-06	20	$5,000,000
2025-10-17	1	N/A

Funding Insights

$5,000,000

Total funding amount

Number of funding rounds

Thryv Therapeutics Tech Stack

Discover the technologies and tools that power Thryv Therapeutics's digital infrastructure, from frameworks to analytics platforms.

Modernizr

JavaScript libraries

reCAPTCHA

Security

lit-element

JavaScript libraries

Google Maps

Maps

lit-html

JavaScript libraries

Stimulus

JavaScript frameworks

HSTS

Security

Google Analytics

Analytics

Google Workspace

Adobe Fonts

Font scripts

Squarespace Commerce

Ecommerce

Google Tag Manager

Tag managers

Frequently asked questions

Thryv Therapeutics is located in Montreal, Quebec, CA.

You can reach Thryv Therapeutics at +15149730915.

Thryv Therapeutics generates an estimated annual revenue of $2,395,540. This revenue figure reflects the company's market position and business performance in its industry.

Thryv Therapeutics has an estimated valuation of $7,700,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Thryv Therapeutics was founded in 2019, making it 7 years old. The company has established itself as a significant player in its industry over this time.

Thryv Therapeutics has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.

Thryv Therapeutics has raised a total of $5,000,000 across 2 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at Thryv Therapeutics

Philip Sager

Co-Founder And Bod Observer

Alicia Schiavi

Associate Director Clinical Operations

Maroua Khalifa

Associate Director, Pharmaceutical Development

Delphine Labit

Research Director

4.8

40,000 users